Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

York University (Toronto, Ontario)

$322,998.00

Novel mechanisms of PDK1 and MEKK3 regulation

FY 2008-09

Summary
Cancer is a disease in which cells of the body become growth deregulated. During development, cell division is normal and is controlled by signals transmitted by a class of proteins called kinases. Normally, the growth of cells is tightly controlled. During cancer, the control of some kinases are lost and signals are sent resulting in inappropriate growth. The current project studies two kinases, PDK1 and MEKK3, that function to control growth and differentiation pathways. We are trying to understand how these kinases operate and what might occur during cancer that causes these kinases to become deregulated. Once we know better how PDK1 and MEKK3 function, we will be able to design therapies that can specifically alter their involvement during cancer.
Program
Operating Grant
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
172149
Name
Scheid Michael P
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Novel mechanisms of PDK1 and MEKK3 regulation
Programtype2
Operating Grants
Orgnameinp2
York University (Toronto, Ontario)
Cihramount2
$322,998
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cancer; Cell Biology; Growth Factor Receptors; Molecular Biology; Proteins Kinases; Signal Transduction
Abstract
Cancer is a disease in which cells of the body become growth deregulated. During development, cell division is normal and is controlled by signals transmitted by a class of proteins called kinases. Normally, the growth of cells is tightly controlled. During cancer, the control of some kinases are lost and signals are sent resulting in inappropriate growth. The current project studies two kinases, PDK1 and MEKK3, that function to control growth and differentiation pathways. We are trying to understand how these kinases operate and what might occur during cancer that causes these kinases to become deregulated. Once we know better how PDK1 and MEKK3 function, we will be able to design therapies that can specifically alter their involvement during cancer.
Competitiondate
200809
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Scheid, Michael P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $322,998~ $0~